Diabetech - Diabetes Tech, Research, News

I spoke with endocrinologist and diabetes tech expert Dr. David Ahn at the ATTD conference about the biggest breakthroughs shaping the future of diabetes management, including the rapid progress toward fully closed-loop insulin delivery systems. We explored how companies like MiniMed, CamAPS, and Omnipod are advancing automation that reduces carb counting, minimizes manual bolusing, and improves time-in-range outcomes. We also discussed emerging topics such as GLP-1 therapies for type 1 diabetes, AI-powered diabetes tools, and continuous glucose-plus-ketone monitoring aimed at preventing diabetic ketoacidosis. We shared key takeaways from ATTD and what these innovations mean for reducing daily diabetes burden while moving closer to a true artificial pancreas. 

 

Learn about Omnipod 5 (today's sponsor)*

 

Learn about the Eversense 365 CGM

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

Join the Diabetech Newsletter

 

Follow David's channels: https://www.instagram.com/ahncall | https://www.tiktok.com/@diabetesdoc | https://x.com/AhnCall

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I spoke with journalist and cure expert Ginger Vieira to unpack major developments including stem-cell therapies, donor islet cell transplants, and the growing debate around the Islet Cell Act currently stalled in U.S. Congress. We examine why promising results from trials like Eledon's still face challenges around safety, scalability, and immunosuppression despite exciting early outcomes and break down the latest breakthroughs in type 1 diabetes cure research, exploring new clinical trials that are bringing some patients closer to insulin independence.

 

Learn about Omnipod 5 (today's sponsor)*

 

Learn about the Eversense 365 CGM

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

The Diabetes Nerd Network

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sit down with Hanne Engan to discuss her experience being detained by ICE during what was supposed to be a routine U.S. green card interview. We unpack how immigration enforcement policies intersected with a life-threatening medical crisis when Hana—who has type 1 diabetes—was denied critical insulin and medical care inside an immigration detention center. Through her firsthand account, we explore the realities of visa overstays, ICE detention practices, and the human impact of immigration policy in the U.S. This powerful conversation sheds light on medical neglect in detention facilities and raises urgent questions about immigrant rights, healthcare access, and accountability.

 

Donate to Hanne's GoFundMe

 

Learn about Omnipod 5 (today's sponsor)*

 

Learn about the Eversense 365 CGM

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

Sources: The Lever | Austin Kocher | Washington Post

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Gary and I break down why insulin doesn’t always work the way we expect—whether it’s absorption issues, site problems, heat exposure, stress, hormones, illness, or exercise. We talk about how automated insulin delivery systems are only as good as the insulin actually getting into your body, and why fixing efficacy often matters more than changing your settings. Gary shares practical strategies for improving absorption, rotating sites effectively, and troubleshooting those “stubborn” highs that won’t come down. We also cover how things like scar tissue, steroid medications, and daily stress can quietly impact insulin sensitivity. If you’ve ever wondered why your numbers feel unpredictable, this episode will help you identify what to adjust before blaming your pump or algorithm.

 

Learn about Omnipod 5 (today's sponsor)*

 

Learn about the Eversense 365 CGM

 

Learn About Integrated Diabetes (Gary’s Practice)

 

Send in YOUR questions about Mealtime Insulin

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I speak with the first patient in a groundbreaking type 1 diabetes cure research trial using encapsulated neonatal pig islet cells—without immunosuppression. Six months after his transplant through the OPF-310 study led by Otsuka Pharmaceutical and University of Illinois Chicago, Michael Revland's insulin needs have been cut in half as the cells have begun maturing and producing insulin. We dive into how this porcine islet cell transplant works, why it differs from stem cell and donor islet trials, and the risks and rewards of pursuing insulin independence. He also shares why he declined an immunosuppression-based transplant study and the emotional highs and lows of being patient number one.

 

Learn about the Eversense 365 CGM

 

Learn about Omnipod 5 (today's sponsor)*

 

Join the Diabetech Newsletter

 

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

 

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.